Answers are grounded in this paper and cite their sources.
Lymphocytoma cutis is the name for a group of skin disorders defined as benign lymphoproliferative reactions that may simulate cutaneous malignant lymphomas clinically and/or histologically. In the literature one may find a large number of confusing names for these conditions, such as sarcoidosis of Spiegler and Fend, lymphocytoma benigna cutis and cutaneous lymphoid hyperplasia (Table 1).1–6 As these pseudolymphomas may mimic cutaneous T-cell lymphomas (CTCL) or cutaneous B-cell lymphomas (CBCL), we prefer to use the designation cutaneous pseudolymphoma for the whole group instead of the term lymphocytoma cutis. Using the term pseudolymphoma one is always alert to differentiate these conditions from malignant cutaneous lymphomas. For that reason also it is wise to get rid of all the various names mentioned in Table 1 and to use only the term cutaneous B- or T-cell pseudolymphoma. Differentiation between pseudolymphoma and CBCL/CTCL may be extremely difficult and should always be based on a combination of clinical and histological data, and can further be facilitated by the use of immunohistochemistry and T-cell receptor (TCR) and immunoglobulin gene rearrangement analysis, either by Southern blotting or by polymerase chain reaction techniques.7–9 Herein, clinical and differential diagnostic aspects of the different types of pseudolymphomas will be discussed. There are many known causes for the development of these pseudolymphomas, but in many patients a definite cause cannot always be found. These various causes may give rise to a lymphocytic reaction in the skin. Depending on the cause (such as infectious agents, foreign bodies, drugs, antigen reactions) this lymphocytic infiltrate may consist predominantly of B cells or T cells. Older terms, such as lymphocytoma benigna cutis, lymphocytoma of the B-cell type, cutaneous B-cell lymphocytoma and sarcoid of Spiegler–Fendt are mentioned for historical reasons only. CBPLs are characterized by a cutaneous infiltrate suggestive of malignant B-cell lymphoma. Patients with CBPL may show mostly a solitary red coloured nodule or plaque. In about 10–15% of the patients more generalized or multifocal skin lesions may be observed. In the majority of the cases there is involvement of the face and scalp, ear lobes and the upper thorax area. This form is more frequently seen in females under 40 years of age than in males. A careful history should be taken to find a possible cause, in particular medication should be queried extensively, as a great variety of stimuli can induce a B-cell reaction; e.g. Borrelia burgdorferi infection, insect bites, trauma, injected drugs, vaccination, acupuncture and tattoos (Table 2). In most cases no aetiological factors can be discovered (idiopathic form). In most cases the infiltrate is located in the papillary dermis (top heavy). This is in contrast to the frequently seen bottom-heavy infiltrate of the malignant cutaneous B-cell lymphomas. The nodular or diffuse polymorphous infiltrate consists of lymphocytes admixed with histiocytes, eosinophils and plasma cells. In some cases a small number of large lymphocytes with a prominent nucleus and nucleoli may be observed. Germinal centres with their characteristic networks of follicular dendritic cells, nuclear dust, admixed T cells and histiocytes, are usually present. These techniques enables us more precisely to distinguish CBPLs from cutaneous malignant B-cell lymphomas. Characteristically, the dermal cellular infiltrate show a mixture of λ and κ light chain positive B cells, which contrasts to the predominance of κ or λ light chains in CBCL. This immunohistochemical technique became the gold standard to differentiate benign from malignant cutaneous B-cell disorders.10,11 Clonality can always be demonstrated by immunoglobulin gene rearrangement analysis. However, caution is warranted, as also in some pseudolymphomas monoclonality can be shown. To distinguish CBPL from malignant primary cutaneous B-cell lymphoma may be very difficult (Table 3). Demonstration of monotypic light chain expression or lack of detectable immunoglobulin on frozen or paraffin-embedded sections of CBCL is the most important differential diagnostic criterion. The diagnosis should always be based on clinical, histological, immunohistochemical and gene rearrangement criteria. One should bear in mind that CBCL can occur as a single lesion in the skin without systemic involvement, in which case the differential diagnosis with pseudolymphoma may be very difficult. It is important to find the cause. In the case of a drug reaction the drug should be eliminated. Borrelia infection should be treated accordingly. Topical corticosteroids may be helpful in other cases of CBPL. Intralesional corticosteroids can be administered in solitary lesions. Low-dose radiotherapy may be considered in selected cases. In case of infections such as Borrelia burgdorferi and drug reactions the skin lesions may resolve normally in 1–8 weeks. Progression of B-cell pseudolymphoma into cutaneous B-cell lymphoma has been reported. A spectrum of B-cell neoplasia ranging from polyclonal pseudolymphoma via oligoclonal and monoclonal pseudolymphoma into malignant B-cell lymphomas has been suggested. The prevalence of Borrelia lymphocytoma cutis has been reported to be from 0.6% to 1.3%. In areas endemic for the tick, Ixodes ricinus, this disease is more common. The areas of predilection are the ear lobe, nipple and areola, and scrotal area. Clinically, it is characterized by a blue–red plaque or nodule of 1–5 cm in diameter. Some itching and tenderness may be present. Regional lymphadenopathy is usually present. Serum antibodies to Borrelia burgdorferi are elevated in 50% of the cases. Older terms are cutaneous T-cell lymphocytoma and cutaneous lymphocytoma of the T-cell type. CTPLs are characterized by the presence of a cutaneous T-cell infiltrate with features suggestive of a cutaneous T-cell lymphoma, and clinical features unlike malignant cutaneous lymphoma.12 The clinical features depend on the aetiology. Well defined entities are lymphomatoid drug reactions, lymphomatoid contact dermatitis, persistent arthropod bite reactions and actinic reticuloid. The skin may show a generalized eruption of papules and plaques to erythroderma (drug reaction), localized dermatitis (contact dermatitis) and nodular eruption (arthropod bite). It may be difficult to find a cause; nevertheless a careful history is mandatory. There is a great variety of drugs capable of producing a cutaneous T-cell reaction. Persistent allergic contact dermatitis, persistent arthropod-bite reactions and actinic reticuloid may give rise to a CTPL reaction (Table 4). Two histological patterns can be distinguished: (i) patients with a band-like infiltrate composed of small lymphocytes with hyperchromatic medium-sized cerebriform nuclei simulating plaque-stage mycosis fungoides (histiocytes can be present in moderate numbers while eosinophils and plasma cells are few or absent and the epidermis may show some acanthosis and spongiosis), and (ii) patients with a nodular pattern may simulate pleomorphic T-cell lymphoma (the histopathology in these cases is characterized by a perivascular infiltrate consisting of lymphoid cells with medium-sized or large cerebriform nuclei and an admixture of small round lymphocytes and occasionally plasma cells). Most of the lymphocytes in the infiltrate are CD4 positive. In human immunodeficiency virus-related pseudolymphomas and actinic reticuloid the majority of the lymphocytes have a CD8-positive phenotype. Loss of T-cell markers as in cutaneous T-cell lymphomas does not occur in pseudolymphomas, and can contribute significantly to differentiate from malignant lymphoma. Clonality cannot be used as single hallmark for pseudolymphomas as in a number of cases TCR gene rearrangements can be demonstrated despite the benign character. It is of utmost importance to differentiate the CTPLs from the malignant cutaneous T-cell lymphomas. The diagnosis should always be based on clinical, histological and immunohistochemical criteria together (Table 5). If a cause is found, therapy should be targeted at this cause. Withdrawal of the causative drug and administering antiparasitic medication in the case of persistent insect bites. Topical or oral corticosteroids can be used depending on the cause of the eruption. In solitary lesions excision may be considered. In a couple of weeks the eruption caused by drugs should resolve when the drug is eliminated. In cases of persistent insect bites (e.g. scabies) it may take more time to cure. Actinic reticuloid is very resistant to treatment, and these patients are have to avoid exposure to sunlight. The majority of drug-induced CTPLs have been reported after the use of anticonvulsant drugs or angiotensin-converting enzyme inhibitors. The minority of the drug reactions are due to the use of various drug such as allopurinol, atenolol, d-penicillamine and penicillin. The patients will show a generalized skin eruption with or without systemic symptoms such as fever and lymphadenopathy. This is a chronic persistent allergic contact dermatitis with histological features similar to mycosis fungoides. The skin may show pruritic, generalized or discrete erythematous, scaly papules and plaques. In all cases the causative allergen is in constant contact with the skin. In some cases the skin lesions are due to a chronic reaction after scabies or an arthropod bite. The patient may show multiple pruritic red–brown papules and nodules on the arms, abdomen and genitals. The reaction is thought to be a delayed-type hypersensitivity reaction to the mite. This is a chronic pruritic photosensitivity dermatitis affecting almost only older men. The skin may show red, lichenoid papules, plaques and nodules on light-exposed skin. In several patients the skin lesions may develop into erythroderma. Severe pruritus is always present. It is important to differentiate actinic reticuloid from Sézary's syndrome. Phototesting and photopatch testing are important in finding a possible causative agent.
No takes yet. Share an insight, caveat, or question.
Vloten et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: